Articles & courses
ArticlesIncretins in Cardiometabolic Medicine: Leveraging GLP-1, GIP, and Glucagon Receptor Agonism for Cardiovascular Risk Reduction
…of incretin based therapies, starting with glucagon like peptide 1 receptor agonists (GLP 1 RAs) and evolving into multi receptor agonists, has unleashed a new…
Media
No matches.
Tests
No matches.
Tools
No matches.